These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 37318056)

  • 21. Molecular mechanism and targets of the antimicrobial activity of metal nanoparticles.
    Oktar FN; Yetmez M; Ficai D; Ficai A; Dumitru F; Pica A
    Curr Top Med Chem; 2015; 15(16):1583-8. PubMed ID: 25877090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities.
    Khorsandi K; Hosseinzadeh R; Sadat Esfahani H; Keyvani-Ghamsari S; Ur Rahman S
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1299-1323. PubMed ID: 33755503
    [No Abstract]   [Full Text] [Related]  

  • 23. Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
    Zhang J; Ba Y; Wang S; Yang H; Hou X; Xu Z
    Eur J Med Chem; 2019 Oct; 179():376-388. PubMed ID: 31260891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and evaluation of aryl-thioether ruthenium polypyridine complexes: A multi-target antimicrobial agents against gram-positive bacteria.
    ChunYan Z; RuJian Y; LiQiang W; HaiYan H; JinTao W; XiangWen L; XueMin D; YanShi X
    Eur J Med Chem; 2022 Oct; 240():114562. PubMed ID: 35777103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in Nanozymes for Bacteria-Infected Wound Therapy.
    Mo F; Zhang M; Duan X; Lin C; Sun D; You T
    Int J Nanomedicine; 2022; 17():5947-5990. PubMed ID: 36510620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activities of transient metals nanoparticles and membranous mechanisms of action.
    Gabrielyan L; Trchounian A
    World J Microbiol Biotechnol; 2019 Oct; 35(10):162. PubMed ID: 31612285
    [TBL] [Abstract][Full Text] [Related]  

  • 27.  Ir(IV) and Ir(III)
    Zhu X; Yang Y; Chen X; Ye G; Liu J; Liu Y
    Biomater Sci; 2023 Jul; 11(14):4960-4971. PubMed ID: 37318056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanozymes used for antimicrobials and their applications.
    Yang D; Chen Z; Gao Z; Tammina SK; Yang Y
    Colloids Surf B Biointerfaces; 2020 Nov; 195():111252. PubMed ID: 32679446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
    Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
    Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
    Lodise TP; Low DE
    Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.